Targeting histone deacetylase in thyroid cancer

Author： Russo Diego   Durante Cosimo   Bulotta Stefania   Puppin Cinzia   Puxeddu Efisio   Filetti Sebastiano   Damante Giuseppe  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.17, Iss.2, 2013-02, pp. : 179-193

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Cancer and Neuropathy with Histone Deacetylase Inhibitors:Two Birds with One Stone?

By  

Current Cancer Drug Targets, Vol. 8, Iss. 4, 2008-06 ,pp. : 266-274

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Histone Deacetylase Inhibitors for Anti-Malarial Therapy

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 3, 2009-02 ,pp. : 292-308

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors: An Attractive Strategy for Cancer Therapy

By  

Current Medicinal Chemistry, Vol. 20, Iss. 14, 2013-05 ,pp. : 1858-1886

Bentham Science Publishers

Access to resources Recommend Favorite

Romidepsin: a novel histone deacetylase inhibitor for cancer

By Bertino Erin M   Otterson Gregory A  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 8, 2011-08 ,pp. : 1151-1158

Informa Healthcare

Access to resources Recommend Favorite

Multi-Targeted Histone Deacetylase Inhibitors in Cancer Therapy

By  

Current Medicinal Chemistry, Vol. 19, Iss. 4, 2012-02 ,pp. : 475-487

Bentham Science Publishers

Access to resources Recommend Favorite